WS #12539
Novo Nordisk sues Eli Lilly over misleading GLP-1 advertising, escalating rivalry in the obesity drug market. Trump targets Canada with 50% tariffs, escalating trade war and adding to market uncertainty.
Pharma Legal Battle
Novo Nordisk sues Eli Lilly over misleading GLP-1 advertising, escalating rivalry in the obesity drug market.
Trump targets Canada with 50% tariffs, escalating trade war and adding to market uncertainty.